410 related articles for article (PubMed ID: 25587898)
1. Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.
Krawczyk A; Dirks M; Kasper M; Buch A; Dittmer U; Giebel B; Wildschütz L; Busch M; Goergens A; Schneweis KE; Eis-Hübinger AM; Sodeik B; Heiligenhaus A; Roggendorf M; Bauer D
PLoS One; 2015; 10(1):e0116800. PubMed ID: 25587898
[TBL] [Abstract][Full Text] [Related]
2. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
[TBL] [Abstract][Full Text] [Related]
4. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
5. Antibody-based immunotherapy of aciclovir resistant ocular herpes simplex virus infections.
Bauer D; Keller J; Alt M; Schubert A; Aufderhorst UW; Palapys V; Kasper M; Heilingloh CS; Dittmer U; Laffer B; Eis-Hübinger AM; Verjans GM; Heiligenhaus A; Roggendorf M; Krawczyk A
Virology; 2017 Dec; 512():194-200. PubMed ID: 28985573
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.
Bauer D; Lu M; Wasmuth S; Li H; Yang Y; Roggendorf M; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):216-25. PubMed ID: 16047184
[TBL] [Abstract][Full Text] [Related]
8. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
Alché LE; Berra A; Veloso MJ; Coto CE
J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
[TBL] [Abstract][Full Text] [Related]
9. Tetrandrine potently inhibits herpes simplex virus type-1-induced keratitis in BALB/c mice.
Hu S; Dutt J; Zhao T; Foster CS
Ocul Immunol Inflamm; 1997 Sep; 5(3):173-80. PubMed ID: 9326762
[TBL] [Abstract][Full Text] [Related]
10. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes.
Doymaz MZ; Rouse BT
Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2165-73. PubMed ID: 1351475
[TBL] [Abstract][Full Text] [Related]
11. 6-Thioguanine Inhibits Herpes Simplex Virus 1 Infection of Eyes.
Chen D; Liu Y; Zhang F; You Q; Ma W; Wu J; Wu Z
Microbiol Spectr; 2021 Dec; 9(3):e0064621. PubMed ID: 34730435
[TBL] [Abstract][Full Text] [Related]
12. [Glycoprotein D (5-23) specific Th2-T-cell line induces HSV-1 keratitis].
Heiligenhaus A; Jayaraman S; Soukiasian S; Dorf M; Foster CS
Ophthalmologe; 1995 Aug; 92(4):484-91. PubMed ID: 7549333
[TBL] [Abstract][Full Text] [Related]
13. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis.
Banerjee K; Biswas PS; Rouse BT
J Leukoc Biol; 2005 Jan; 77(1):24-32. PubMed ID: 15496448
[TBL] [Abstract][Full Text] [Related]
14. A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice.
Miller JK; Laycock KA; Umphress JA; Hook KK; Stuart PM; Pepose JS
Cornea; 1996 Sep; 15(5):497-504. PubMed ID: 8862927
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice.
Komatsu K; Miyazaki D; Morohoshi K; Kuo CH; Kakimaru-Hasegawa A; Komatsu N; Namba S; Haino M; Matsushima K; Inoue Y
Curr Eye Res; 2008 Sep; 33(9):736-49. PubMed ID: 18798077
[TBL] [Abstract][Full Text] [Related]
16. Topical antisense-oligonucleotides targeting IFN-gamma mRNA improve incidence and severity of herpetic stromal keratitis by cytokine specific and sequence unspecific effects.
Wasmuth S; Bauer D; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):443-51. PubMed ID: 18030487
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells.
Jayaraman S; Heiligenhaus A; Rodriguez A; Soukiasian S; Dorf ME; Foster CS
J Immunol; 1993 Nov; 151(10):5777-89. PubMed ID: 8228262
[TBL] [Abstract][Full Text] [Related]
18. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
[TBL] [Abstract][Full Text] [Related]
19. Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody.
Krawczyk A; Arndt MA; Grosse-Hovest L; Weichert W; Giebel B; Dittmer U; Hengel H; Jäger D; Schneweis KE; Eis-Hübinger AM; Roggendorf M; Krauss J
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6760-5. PubMed ID: 23569258
[TBL] [Abstract][Full Text] [Related]
20. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
